<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2A32DD5F-F7BB-4A97-AD11-B00CA5D387A7"><gtr:id>2A32DD5F-F7BB-4A97-AD11-B00CA5D387A7</gtr:id><gtr:name>Dartmouth College</gtr:name><gtr:address><gtr:line1>Dartmouth College</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:department>Biomedical Sciences</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2A32DD5F-F7BB-4A97-AD11-B00CA5D387A7"><gtr:id>2A32DD5F-F7BB-4A97-AD11-B00CA5D387A7</gtr:id><gtr:name>Dartmouth College</gtr:name><gtr:address><gtr:line1>Dartmouth College</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DFCB4295-40A1-4065-9A90-983FC286D23B"><gtr:id>DFCB4295-40A1-4065-9A90-983FC286D23B</gtr:id><gtr:firstName>Tim</gtr:firstName><gtr:surname>Green</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0200084"><gtr:id>3A628ACD-E81B-47B0-9D35-15EB272250AD</gtr:id><gtr:title>Relating Function to Structure in Ionotropic Glutamate Receptors</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0200084</gtr:grantReference><gtr:abstractText>The human brain is estimated to have around 100 billion nerve cells, each one making an average of 10,000 connections with other cells. Rapid communication in the brain primarily involves electrical signals, but in signalling between cells a different system is used. A chemical messenger (neurotransmitter) is released from one cell, and this chemical is detected by specialised receptor proteins on the neighbouring cell. When these receptors detect neurotransmitters they change shape, effectively creating tiny holes in the cell, generating a small electrical signal that can then continue through the cell. Some neurotransmitters increase the level of brain activity (excitation), while others reduce it (inhibition). The correct functioning of the brain relies on a delicate balance between the two, with excess activity for example leading to epilepsy, and contributing to the slow degeneration seen in Alzheimer?s and Parkinson?s diseases.
This research project involves the study of how one class of receptor protein, the glutamate receptors, change shape at the atomic level in response to the neurotransmitter glutamate. To do this controlled changes (mutations) will be introduced into the receptor. The effects of these mutations on the way the receptor protein works will be studied by measuring the electrical signals they generate. By studying the effects of these mutations, it will be possible to identify the key elements of the receptor. This will enable us to describe in more detail how the receptors work. This in turn should ultimately lead to a better understanding of how glutamate receptors interact with drugs, and could potentially lead to the design of drugs that act on these receptors in a more controlled way.</gtr:abstractText><gtr:technicalSummary>The aim of this research is to provide a better understanding of the molecular mechanisms underlying ionotropic glutamate receptor (iGluR) activation. These receptors are the primary mediators of excitatory synaptic signals in the mammalian central nervous system. As such, they have been implicated in a number of neuropathologies, including epilepsy and excitotoxic cell death, although their ubiquity has so far limited their utility as drug targets.
We intend to use mutagenesis, in combination with detailed functional characterisation by electrophysiology and equilibrium binding assays, to identify the residues and interactions within the agonist binding domain that control iGluR gating. There are three interrelated elements to the proposed study. The first is the identification of residues within the binding site that are involved in gating. This will be done by characterising the effects of mutations made in the isolated agonist binding domain, in which the receptor binding site is separated from the ion channel and other gating machinery. The second element is the identification of the subunit interfaces, which are involved in receptor function through allosteric modulation. They will be identified by probing the sensitivity of residues on the surface of the agonist binding domain to mutagenesis, since residues within an interface are less tolerant of changes than residues facing solvent. In the third stage, interactions made by residues identified in the first two stages will be identified using double mutant cycles. The phenotypes of these mutants will be used to categorise their role in receptor activation. In this way, it will be possible to build up a map of the contacts formed within the agonist binding domain and between subunits in different iGluR functional states. This data will advance our understanding of the structural basis of iGluR activation and ultimately may aid the rational design of more selective drugs.</gtr:technicalSummary><gtr:fund><gtr:end>2008-07-06</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-07-07</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>493795</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Dartmouth College</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>iGluR biophysical characterisation</gtr:description><gtr:id>8A7FE192-74C7-4B2B-8521-E4D6D71092BE</gtr:id><gtr:impact>Data published in PUBMED:19561126</gtr:impact><gtr:outcomeId>BEFE8F37368-1</gtr:outcomeId><gtr:partnerContribution>Carried out biophysical characterisation of protein prepared in my laboratory.</gtr:partnerContribution><gtr:piContribution>US lab carried out analytical ultracentrifugation and other biophysical tests on our glutamate receptor mutants.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Open Days</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>610B1B2B-4282-4D35-A426-0DE6C3EEE549</gtr:id><gtr:impact>Presenting information on research interests to prospective undergraduate students and their parents

Hopefully encouraged some in audience to consider a career in research</gtr:impact><gtr:outcomeId>EF79A35A6B1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Kainate receptor mutants with modified desensitisation properties</gtr:description><gtr:id>8986CB21-6778-41C3-B78C-D7E88CC0E8B8</gtr:id><gtr:impact>Improved understanding of mechanisms underlying glutamate receptor desensitisation</gtr:impact><gtr:outcomeId>682CF07BE47</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>iGluR mutants</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BCFDE29D-8623-43D3-88B5-4802951BEFBE</gtr:id><gtr:title>A nondesensitizing kainate receptor point mutant.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29650336c822991a308982f5a0a01f78"><gtr:id>29650336c822991a308982f5a0a01f78</gtr:id><gtr:otherNames>Nayeem N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>84B44D66174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>868C58A5-58AD-47DF-945F-065BBAE3743A</gtr:id><gtr:title>Interface interactions modulating desensitization of the kainate-selective ionotropic glutamate receptor subunit GluR6.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d895db59e431e55ec84105d0da4fab0d"><gtr:id>d895db59e431e55ec84105d0da4fab0d</gtr:id><gtr:otherNames>Zhang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>85456352B0B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>581B16DB-968D-47E9-8175-5BA9247D0E32</gtr:id><gtr:title>Mutations to the kainate receptor subunit GluR6 binding pocket that selectively affect domoate binding.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d895db59e431e55ec84105d0da4fab0d"><gtr:id>d895db59e431e55ec84105d0da4fab0d</gtr:id><gtr:otherNames>Zhang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>B7AA0550C7D</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0200084</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>